Prevalence of deleterious variants in cardiomyopathy genes in early-onset atrial fibrillation

早发性房颤患者中心肌病基因有害变异的患病率

阅读:2

Abstract

Atrial fibrillation (AF) is a common cardiac arrhythmia associated with an increased risk of stroke, heart failure, and death. Recent studies suggest that early-onset AF increases the risk of developing heart failure and dilated cardiomyopathy. This study aims to identify genetic variants in a large set of cardiomyopathy genes among early-onset AF individuals. We conducted targeted sequencing of 29 cardiomyopathy-associated genes in 478 individuals from a Danish cohort with early AF onset. Additionally, we analyzed whole exome sequencing data from 374,289 individuals from the UK Biobank, including 29,108 individuals with AF. 8.8% of the Danish individuals with early-onset AF carry truncating variants in cardiomyopathy-associated genes. The prevalence of truncating variants in the UK Biobank analysis ranges from 3.8% in the group with early AF onset to 1.4% in the group without AF diagnosis. This suggests that genetic testing for cardiomyopathy could be relevant in selected individuals with early AF diagnosis.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。